Nano Magic Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-11-12: Form 8-K; Period of report 2013-11-07; Description 8.01 Other Events; Details 8.01.
- 2013-10-31: Form 8-K; Period of report 2013-10-31; Description 8.01 Other Events; Details 8.01.
- 2013-09-05: Form 8-K; Period of report 2013-09-05; Description 8.01 Other Events; Details 8.01.
- 2013-09-05: Form 8-K; Period of report 2013-09-03; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-11-12 | 8-K | 2013-11-07 | 8.01 Other Events | 8.01 On November 7, 2013, Applied Nanotech Holdings, Inc. ("we”, "us” or “our”) issued a joint press release with Nanofilm, Ltd. regarding their planned merger. | applied_8k-110713.htm |
| 2013-10-31 | 8-K | 2013-10-31 | 8.01 Other Events | 8.01 On October 31, 2013, Applied Nanotech Holdings, Inc. ("we”, "us” or “our”) issued a joint press release with Nanofilm, Ltd. regarding their planned stock swap transaction. | appliednano_8k.htm |
| 2013-09-05 | 8-K | 2013-09-05 | 8.01 Other Events | 8.01 The Company has posted its latest shareholder letter on its website at www.appliednanotech.net in the investor information section. | appliednano_8k.htm |
| 2013-09-05 | 8-K | 2013-09-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective September 3, 2013, Alan Jernigan, CEO of EZDiagnostix, Inc, a subsidiary of the Company ceased employment as a result of a restructuring of the Company that caused a reduction in the workforce. | appliednano_8k.htm |
| 2013-08-21 | 8-K | 2013-08-19 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 In a report on Form 8-K dated April 10, 2013, the Company reported an increase in the compensation of its Chairman, Dr. Robert Ronstadt to $52,000 per year for 2013. | appliednano_8k.htm |
| 2013-08-06 | 8-K | 2013-08-05 | 8.01 Other Events | 8.01 The Company has posted its latest shareholder letter on its website at www.appliednanotech.net in the investor information section. | appliednano_8k-080513.htm |
| 2013-05-31 | 8-K | 2013-05-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective May 31, 2013, Tracy Bramlett resigned as a member of the Board of Directors of the Company. | anhi_8k-053113.htm |
| 2013-05-10 | 8-K | 2013-05-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective May 10, 2013, Chief Executive Officer Douglas P. Baker resigned as CEO at the request of the Board of Directors of the Company. | appliednano_8k.htm |
| 2013-04-12 | 8-K | 2013-04-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | appliednano_8k.htm | |
| 2013-03-20 | 8-K | 2013-03-20 | 8.01 Other Events | 8.01 The Company has posted its latest shareholder letter on its website at www.appliednanotech.net in the investor information section. | applied_8k.htm |